Clinical Trial Update: Monovalent Chimpanzee Adenoviral-Vectored Marburg Virus Vaccine in Healthy Adults [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of a monovalent chimpanzee adenoviral-vectored Marburg virus vaccine in healthy adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Marburg Virus Disease

Drugs mentioned

• Monovalent Chimpanzee Adenoviral-Vectored Marburg Virus Vaccine (Monovalent chimpanzee adenoviral-vectored Marburg virus vaccine)

Snippet

Sponsor: Albert B. Sabin Vaccine Institute | Conditions: Marburg Virus Disease | Phase 2 | Status: COMPLETED